BioNTech SE (BNTX) Return on Sales (2018 - 2025)

BioNTech SE has disclosed Return on Sales across 8 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Sales for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.13%, down 13.0% from the prior year.
• Return on Sales came in at 0.0% for Q4 2025 at BioNTech SE, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2021 to a low of 0.54% in Q2 2025.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.05%.
• Peak annual rise in Return on Sales reached 14 bps in 2025, while the deepest fall reached 47 bps in 2025.
• BioNTech SE's Return on Sales stood at 0.01% in 2021, then soared by 66 bps to 0.01% in 2022, then tumbled by 67 bps to 0.0% in 2023, then tumbled by 100 bps to 0.0% in 2024, then slumped by 210037 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.54% (Q2 2025), per Business Quant data.